SPOTLIGHT -
Lung Cancer Treatment-Related Toxicities
Giorgio V. Scagliotti, MD, PhD, discusses toxicities related to chemotherapy and surgery in patients with lung cancer.
Afatinib in Patients With an EGFR Mutation
Giorgio V. Scagliotti, MD, PhD, from the University of Turin, San Luigi Hospital, Orbassano, Italy, discusses afatinib in patients with EGFR-mutated tumors.
Recent Findings on Molecular Genotyping in Lung Cancer
Giorgio V. Scagliotti, MD, PhD, from the University of Turin, discusses recent advances in the molecular genotyping of patients with lung cancer.
